FDA Grants DeNovo Clearance To Atlantic Therapeutics For INNOVO Therapy Device
Jan 2, 2019 @ 14:42

the U.S. Food and Drug Administration (FDA) has granted a DeNovo clearance for its INNOVO therapy device, an externally worn electrical muscle stimulator for the treatment of stress urinary incontinence in adult females.

INNOVO is the first transcutaneous electrical stimulation continence device to be cleared by the FDA

Sourced through Scoop.it from: www.mpo-mag.com

Leave a Reply